Wallaby Medical stroke treatment

Wallaby Medical closes US$45 million Series C funding

Wallaby Medical, a medical device company focused on stroke treatment, has announced the closing of a US$45 million Series C funding. This round of funding...

Rapid Medical receives CE mark for remodelling mesh device

Rapid Medical has announced that its adjustable remodelling mesh device, called Comaneci, has received CE mark approval. Comaneci is intended to treat cerebral vasospasm...

Society of Vascular and Interventional Neurology releases study on paradigm shifts in medical care...

The Society of Vascular and Interventional Neurology (SVIN) colleagues and James Siegler (Cooper University Hospital, Camden, USA)  identify that it should come as no surprise...

Boston Scientific launches Vercise Genus DBS on European Market

Boston Scientific has announced that its Vercise Genus deep brain stimulation (DBS) device has received a CE Mark. This is a fourth generation device...

Jens Fiehler

Richard P Klucznik

Jesse Dawson NeuroNews

Jesse Dawson